Sinusitis Exclusion From Nasal Decongestant Labels Is Unsupported – Pfizer
This article was originally published in The Tan Sheet
Executive Summary
Physician intervention could be the only recourse for consumers suffering from sinusitis if FDA were to remove the indication from OTC product labels, according to Pfizer Consumer Healthcare